Display Settings:

Format

Send to:

Choose Destination
    Postgrad Med. 1991 Apr;89(5):175-8, 180.

    Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.

    Source

    Department of Medicine, Good Samaritan Hospital, Phoenix, AZ 85006.

    Abstract

    Neuroleptic malignant syndrome has been described in patients receiving dopamine antagonists and in a few patients after withdrawal of dopaminergic antiparkinson therapy. Complications affect almost all organ systems and can be life-threatening. Most patients have fever, altered level of consciousness, bradykinesia, and rigidity. Treatment includes withdrawal of the causative agent and supportive therapy for complications. When withdrawal of a dopaminergic medication is the suspected cause, the agent should be reinstated.

    PMID:
    2008397
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk